One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease.
Mankerious N, Toelg R, Vogel B, Sartori S, Angiolillo DJ, Vranckx P, Feng Y, de la Torre Hernandez JM, Krucoff MW, Bhatt DL, Spirito A, Cao D, Chehab BM, Kunadian V, Maksoud A, Picon H, Sardella G, Thiele H, Varenne O, Windecker S, Richardt G, Valgimigli M, Mehran R.
Mankerious N, et al. Among authors: mehran r.
Am J Cardiol. 2024 Aug 15;225:25-34. doi: 10.1016/j.amjcard.2024.06.003. Epub 2024 Jun 12.
Am J Cardiol. 2024.
PMID: 38871156